Millennium Management’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $353K | Buy |
+296,239
| New | +$353K | ﹤0.01% | 3508 |
|
|
2024
Q4 | – | Sell |
-39,750
| Closed | -$278K | – | 4028 |
|
|
2024
Q3 | $278K | Buy |
+39,750
| New | +$278K | ﹤0.01% | 3590 |
|
|
2024
Q2 | – | Sell |
-95,497
| Closed | -$683K | – | 3919 |
|
|
2024
Q1 | $683K | Buy |
+95,497
| New | +$683K | ﹤0.01% | 3158 |
|
|
2023
Q1 | – | Sell |
-19,639
| Closed | -$226K | – | 4468 |
|
|
2022
Q4 | $226K | Buy |
+19,639
| New | +$226K | ﹤0.01% | 4035 |
|